155 related articles for article (PubMed ID: 36763251)
21. Concentration of survivin in children with oligo- and polyarticular juvenile idiopathic arthritis (JIA): diagnostic and prognostic value-a single-center study.
Lipinska J; Kaszkowiak M; Malachowska B; Swidrowska-Jaros J; Smolewska E
Arthritis Res Ther; 2021 Jan; 23(1):40. PubMed ID: 33494811
[TBL] [Abstract][Full Text] [Related]
22. Cumulative Damage in Juvenile Idiopathic Arthritis: A Multicenter Study From the Pediatric Rheumatology Arab Group.
Al-Mayouf SM; Hashad S; Khawaja K; Alrasheedi A; Abdwani R; Abushhaiwia A; AlSuwaiti M; Alzyoud R; Al Abrawi S; Asiri A; Alshaikh M; Sharif E; Muzaffer M; Alsewairi W; Zlenti M; Kawaja E; Almutairi M; Majeed M; Lotfy H; AlMarri M; Almutairi N;
Arthritis Care Res (Hoboken); 2021 Apr; 73(4):586-592. PubMed ID: 32886859
[TBL] [Abstract][Full Text] [Related]
23. Physical activity assessment in children and adolescents with juvenile idiopathic arthritis compared with controls.
Fazaa A; Sellami M; Ouenniche K; Miladi S; Kassab S; Chekili S; Ben Abdelghani K; Laatar A
Arch Pediatr; 2021 Jan; 28(1):47-52. PubMed ID: 33250332
[TBL] [Abstract][Full Text] [Related]
24. A Comparison of International League of Associations for Rheumatology and Pediatric Rheumatology International Trials Organization Classification Systems for Juvenile Idiopathic Arthritis Among Children in a Canadian Arthritis Cohort.
Lee JJY; Eng SWM; Guzman J; Duffy CM; Tucker LB; Oen K; Yeung RSM; Feldman BM;
Arthritis Rheumatol; 2022 Aug; 74(8):1409-1419. PubMed ID: 35289119
[TBL] [Abstract][Full Text] [Related]
25. Serum amyloid A circulating levels and disease activity in patients with juvenile idiopathic arthritis.
Cantarini L; Giani T; Fioravanti A; Iacoponi F; Simonini G; Pagnini I; Spreafico A; Chellini F; Galeazzi M; Cimaz R
Yonsei Med J; 2012 Sep; 53(5):1045-8. PubMed ID: 22869491
[TBL] [Abstract][Full Text] [Related]
26. Outcome of children with oligoarticular juvenile idiopathic arthritis compared to polyarthritis on methotrexate- data of the German BIKER registry.
Raab A; Kallinich T; Huscher D; Foeldvari I; Weller-Heinemann F; Dressler F; Kuemmerle-Deschner JB; Klein A; Horneff G
Pediatr Rheumatol Online J; 2021 Mar; 19(1):41. PubMed ID: 33752685
[TBL] [Abstract][Full Text] [Related]
27. Sleep and its relationship to pain, dysfunction, and disease activity in juvenile idiopathic arthritis.
Shyen S; Amine B; Rostom S; E L Badri D; Ezzahri M; Mawani N; Moussa F; Gueddari S; Wabi M; Abouqal R; Chkirate B; Hajjaj-Hassouni N
Clin Rheumatol; 2014; 33(10):1425-31. PubMed ID: 24135889
[TBL] [Abstract][Full Text] [Related]
28. Long-Term Outcomes in Juvenile Idiopathic Arthritis: Eighteen Years of Follow-Up in the Population-Based Nordic Juvenile Idiopathic Arthritis Cohort.
Glerup M; Rypdal V; Arnstad ED; Ekelund M; Peltoniemi S; Aalto K; Rygg M; Toftedal P; Nielsen S; Fasth A; Berntson L; Nordal E; Herlin T;
Arthritis Care Res (Hoboken); 2020 Apr; 72(4):507-516. PubMed ID: 30762291
[TBL] [Abstract][Full Text] [Related]
29. Expanded population of low-density neutrophils in juvenile idiopathic arthritis.
Parackova Z; Zentsova I; Bloomfield M; Klocperk A; Horvath R; Malcova H; Cebecauerova D; Sediva A
Front Immunol; 2023; 14():1229520. PubMed ID: 37915575
[TBL] [Abstract][Full Text] [Related]
30. [Role of CD4
Wang JY; Zhu XP; Zhang Y; Luo C; Tang XM; Zhou J
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Feb; 25(2):166-171. PubMed ID: 36854693
[TBL] [Abstract][Full Text] [Related]
31. Predictors of the response to etanercept in patients with juvenile idiopathic arthritis without systemic manifestations within 12 months: results of an open-label, prospective study conducted at the National Scientific and Practical Center of Children's Health, Russia.
Alexeeva EI; Namazova-Baranova LS; Bzarova TM; Valieva SI; Denisova RV; Sleptsova TV; Isaeva KB; Chomahidze AM; Taibulatov NI; Fetisova AN; Karaseva AV; Baranov AA
Pediatr Rheumatol Online J; 2017 Jun; 15(1):51. PubMed ID: 28615036
[TBL] [Abstract][Full Text] [Related]
32. Biotherapy in juvenile idiopathic arthritis Moroccan patients: a single-center experience.
Bouayed K; Hamraoui D; Mikou N; Sakhi A; Hilmi W
Pan Afr Med J; 2022; 41():135. PubMed ID: 35519160
[TBL] [Abstract][Full Text] [Related]
33. [Characteristics of synovial fluid in patients with juvenile idiopathic arthritis].
Martínez Del Val E; Rodríguez Martínez A; Sánchez Becerra V; Cruz Rojo J; Enríquez Merayo E; Barral Mena E; de Inocencio Arocena J
An Pediatr (Engl Ed); 2019 Oct; 91(4):244-250. PubMed ID: 30782446
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and significance of serum 14-3-3η in juvenile idiopathic arthritis.
Reyhan I; Zhukov OS; Lagier RJ; Bridgforth RF; Williams GJ; Popov JM; Naides SJ; Reiff A
Pediatr Rheumatol Online J; 2021 Feb; 19(1):14. PubMed ID: 33593401
[TBL] [Abstract][Full Text] [Related]
35. Anti-cyclic citrullinated peptide (anti-CCP) antibody in juvenile idiopathic arthritis (JIA): correlations with disease activity and severity of joint damage (a multicenter trial).
Omar A; Abo-Elyoun I; Hussein H; Nabih M; Atwa H; Gad S; Emad Y
Joint Bone Spine; 2013 Jan; 80(1):38-43. PubMed ID: 22575064
[TBL] [Abstract][Full Text] [Related]
36. [Comparison of the Disease Activity Score-28 and Juvenile Arthritis Disease Activity Score in the juvenile idiopathic arthritis].
Capela RC; Corrente JE; Magalhães CS
Rev Bras Reumatol; 2015; 55(1):31-6. PubMed ID: 25440705
[TBL] [Abstract][Full Text] [Related]
37. Performance of rheumatoid arthritis disease activity measures and juvenile arthritis disease activity scores in polyarticular-course juvenile idiopathic arthritis: Analysis of their ability to classify the American College of Rheumatology pediatric measures of response and the preliminary criteria for flare and inactive disease.
Ringold S; Bittner R; Neogi T; Wallace CA; Singer NG
Arthritis Care Res (Hoboken); 2010 Aug; 62(8):1095-102. PubMed ID: 20506561
[TBL] [Abstract][Full Text] [Related]
38. Reactive oxygen species and serum antioxidant defense in juvenile idiopathic arthritis.
Lipińska J; Lipińska S; Stańczyk J; Sarniak A; Przymińska vel Prymont A; Kasielski M; Smolewska E
Clin Rheumatol; 2015 Mar; 34(3):451-6. PubMed ID: 24651913
[TBL] [Abstract][Full Text] [Related]
39. The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus.
Bobek D; Grčević D; Kovačić N; Lukić IK; Jelušić M
Pediatr Rheumatol Online J; 2014; 12():50. PubMed ID: 25516724
[TBL] [Abstract][Full Text] [Related]
40. Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis.
Swart JF; van Dijkhuizen EHP; Wulffraat NM; de Roock S
Ann Rheum Dis; 2018 Mar; 77(3):336-342. PubMed ID: 29138257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
